APA (7th ed.) Citation

Ono, Y., Sakai, K., Okamura, T., Okada, H., Obora, A., Kojima, T., . . . Fukui, M. (2025, January). Metabolic dysfunction-associated steatotic liver disease (MASLD) can be a possible predictive factor of incident CKD: NAGALA cohort study. PLoS ONE.

Chicago Style (17th ed.) Citation

Ono, Yuriko, Kimiko Sakai, Takuro Okamura, Hiroshi Okada, Akihiro Obora, Takao Kojima, Masahide Hamaguchi, and Michiaki Fukui. "Metabolic Dysfunction-associated Steatotic Liver Disease (MASLD) Can Be a Possible Predictive Factor of Incident CKD: NAGALA Cohort Study." PLoS ONE Jan. 2025.

MLA (9th ed.) Citation

Ono, Yuriko, et al. "Metabolic Dysfunction-associated Steatotic Liver Disease (MASLD) Can Be a Possible Predictive Factor of Incident CKD: NAGALA Cohort Study." PLoS ONE, Jan. 2025.